Amelie Tiritilli1, Cynthia Ko2. 1. Division of Gastroenterology, Department of Medicine, School of Medicine, University of Washington, Box 356424, Seattle, WA, USA. act11@uw.edu. 2. Division of Gastroenterology, Department of Medicine, School of Medicine, University of Washington, Box 356424, Seattle, WA, USA. CynthiaK@medicine.washington.edu.
Abstract
BACKGROUND: While overall colorectal cancer (CRC) rates in the USA are declining, the incidence of early-onset CRC (eoCRC) under age 50 is increasing. The aim of this study was to examine the risk of a second primary malignancy (SPM) in individuals with eoCRC, and how this risk compares to those with late-onset CRC (loCRC). METHODS: We used data from the Surveillance, Epidemiology, and End Results Program database to examine the risk of SPM after a diagnosis of eoCRC. Standardized incidence ratios (SIR) were used to estimate the risk of SPM after eoCRC and loCRC in comparison with the risk of malignancy in the general population. RESULTS: Compared to the general population, individuals with eoCRC, but not loCRC, had an increased lifetime risk of SPM (SIR 1.42, 95% CI 1.37-1.48 and SIR 1.00, 95% CI 0.99-1.02, respectively), and locations at highest risk were the small intestine, ureter, rectum, and colon. The risk of SPM after eoCRC was similar in men and women, but higher in non-whites compared to whites and higher in those with a lower area-level median household income. The risk of SPM following eoCRC was high in the first 5 years after diagnosis (SIR 2.44, 95% CI 2.24-2.66) and, in a birth cohort analysis, was found to be increasing over time. CONCLUSIONS: Individuals with eoCRC have a lifetime risk of SPM nearly 50% higher than the general population. The risk of SPM is highest in the first 5 years after diagnosis and is increasing over time.
BACKGROUND: While overall colorectal cancer (CRC) rates in the USA are declining, the incidence of early-onset CRC (eoCRC) under age 50 is increasing. The aim of this study was to examine the risk of a second primary malignancy (SPM) in individuals with eoCRC, and how this risk compares to those with late-onset CRC (loCRC). METHODS: We used data from the Surveillance, Epidemiology, and End Results Program database to examine the risk of SPM after a diagnosis of eoCRC. Standardized incidence ratios (SIR) were used to estimate the risk of SPM after eoCRC and loCRC in comparison with the risk of malignancy in the general population. RESULTS: Compared to the general population, individuals with eoCRC, but not loCRC, had an increased lifetime risk of SPM (SIR 1.42, 95% CI 1.37-1.48 and SIR 1.00, 95% CI 0.99-1.02, respectively), and locations at highest risk were the small intestine, ureter, rectum, and colon. The risk of SPM after eoCRC was similar in men and women, but higher in non-whites compared to whites and higher in those with a lower area-level median household income. The risk of SPM following eoCRC was high in the first 5 years after diagnosis (SIR 2.44, 95% CI 2.24-2.66) and, in a birth cohort analysis, was found to be increasing over time. CONCLUSIONS: Individuals with eoCRC have a lifetime risk of SPM nearly 50% higher than the general population. The risk of SPM is highest in the first 5 years after diagnosis and is increasing over time.
Authors: Laura A E Hughes; Veerle Melotte; Joachim de Schrijver; Michiel de Maat; Vincent T H B M Smit; Judith V M G Bovée; Pim J French; Piet A van den Brandt; Leo J Schouten; Tim de Meyer; Wim van Criekinge; Nita Ahuja; James G Herman; Matty P Weijenberg; Manon van Engeland Journal: Cancer Res Date: 2013-06-25 Impact factor: 12.701
Authors: Christina E Bailey; Chung-Yuan Hu; Y Nancy You; Brian K Bednarski; Miguel A Rodriguez-Bigas; John M Skibber; Scott B Cantor; George J Chang Journal: JAMA Surg Date: 2015-01 Impact factor: 14.766
Authors: Lisa A Boardman; Ruth A Johnson; Gloria M Petersen; Ann L Oberg; Brian F Kabat; Joshua P Slusser; Liang Wang; Bruce W Morlan; Amy J French; Thomas C Smyrk; Noralane M Lindor; Stephen N Thibodeau Journal: Clin Cancer Res Date: 2007-04-15 Impact factor: 12.531
Authors: Andrea J Dwyer; Caitlin C Murphy; C Richard Boland; Reese Garcia; Heather Hampel; Paul Limburg; Jan Lowery; Ann G Zauber; Stephen Waring; Sharyn Worrall; Jose Perea; Rebecca Siegel; Jeffrey Lee; Christine Molmenti; Cynthia L Sears; Phillip Buckhaults; Richard Hayes; Hisham Hussan; Noel de Miranda; Claire Palles; Luis Diaz; Mingyang Song; Andrea Cercek; Christopher H Lieu; Swati G Patel; Jordan J Karlitz; Yin Cao; Josh Demb; Patrick Blatchford; Betsy Risendal; Elsa Weltzien; Anil Wali; Phil Daschner; Holli Loomans-Kropp; R Flores; Caleb L Levell; Karen Wehling; Jessica Martin; Curt Pesmen; Violet Kuchar; Ryan Soisson; Anjee Davis; Dennis Ahnen Journal: Gastroenterology Date: 2019-05-13 Impact factor: 22.682
Authors: Nicholas Donin; Christopher Filson; Alexandra Drakaki; Hung-Jui Tan; Alex Castillo; Lorna Kwan; Mark Litwin; Karim Chamie Journal: Cancer Date: 2016-07-05 Impact factor: 6.860